Biomedtracker is a real-time database that identifies biotech and pharma investment opportunities by assessing drug pipelines and future catalysts.
BioMedTracker is an institutional research service that identifies investment opportunities in the biotech and pharmaceutical industry by assessing the relative strength of companies’ clinical drug pipelines and by highlighting potential future catalysts that could dramatically impact those pipelines.
The BioMedTracker team looks at clinical trial data and the regulatory history of each drug under coverage to assess its overall likelihood of approval by the FDA. Each Impact Event that affects the likelihood of approval of the drug is transparent so that subscribers can see the rationale for the analysis. Drugs are further analyzed for their commercial potential and presented in a 10-year Revenue Detail model for the U.S., Europe and Japan. Dates of approval, target patient populations, annual wholesale prices, market penetration, and other factors are estimated in formulating these revenue projections.